Taggart Gauvain, MD
Foot and Ankle Surgery · Pearland, TXNPI 1558612119
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $142,371 of the $201,791 with a category attached, or 70.6%. 36 manufacturers reported payments, led by International Life Sciences at 38.3% of the total. Among foot and ankle surgery clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 265 payments — averaging $761.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- International Life Sciences$77K
- Linvatec Corporation$36K
- Stryker$34K
- Vilex LLC$33K
- In2bones USA, LLC$11K
- Fusion Orthopedics USA, LLC$2K
- plus $9K from 30 others
Across 8 payments — averaging $12,232 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Skye Orthobiologics LLC$73K
- Paragon 28, Inc.$25K
What the payments were for
- Royalty or licence$2,8371%
- Consulting fees$142,37171%
- Speaking & faculty fees$2,0001%
- Grants$2,5001%
- Travel & lodging$34,73017%
- Food & beverage$16,1538%
- Education$1,2001%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| International Life Sciences | 23 | $77,281 |
| Linvatec Corporation | 26 | $36,185 |
| Stryker(2 entities) | 85 | $33,865 |
| Vilex LLC | 31 | $32,838 |
| In2bones USA, LLC | 15 | $10,574 |
| Fusion Orthopedics USA, LLC | 5 | $2,218 |
| Medinc Of Texas | 14 | $2,189 |
| Extremity Medical | 1 | $855 |
| Royal Biologics, Inc. | 2 | $693 |
| Paragon 28, Inc. | 4 | $668 |
| Medshape, Inc. | 6 | $612 |
| Alafair Biosciences, Inc. | 4 | $556 |
| Treace Medical Concepts, Inc. | 6 | $434 |
| Zimmer Biomet | 5 | $433 |
| Innovation Technologies Inc | 2 | $301 |
| Trilliant Surgical LLC. | 3 | $273 |
| Bone Support Inc. | 2 | $264 |
| Osteocentric Technologies, Inc. | 2 | $236 |
| Acera Surgical, Inc. | 1 | $133 |
| Nevro Corp. | 1 | $130 |
| Organogenesis Inc. | 6 | $125 |
| Johnson & Johnson | 1 | $123 |
| Arthrex | 1 | $116 |
| Exactech, Inc. | 1 | $110 |
| Medline Industries LP | 1 | $91 |
| Voom Medical Devices, Inc. | 1 | $89 |
| Davol Inc. | 1 | $77 |
| Ossur Americas, Inc. | 5 | $60 |
| Smith+Nephew | 1 | $39 |
| Integra Lifesciences Corporation | 2 | $39 |
| Theramicro, Inc. | 1 | $36 |
| Axogen | 1 | $35 |
| Globus Medical | 1 | $32 |
| Amgen | 2 | $30 |
| Encore Medical, LP | 1 | $28 |
| Medtronic | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FLEXBAND$65,156
- mild Device Kit$27,500
- NeoSpan$16,622
- Next Gen Ankle$14,853
- HINTERMANN$13,343
- 7 X 23MM CITRELOCK IMPLANT$12,096
- CITREFIX$11,385
- CoLink$10,272
- COLINK PLATING SYSTEM$8,698
- QUANTUM$6,833
- BioBrace 23mm$4,399
- Next Gen Ankle - R&D$4,253
- PROPHECY$2,671
- PROstep$2,500
- HOFFMANN$564
- VersaWrap$517
- COLINK 2$512
- INFINITY ADAPTIS$484
- T2$475
- SALVATION$448
How this compares
$201,791 in reported general payments places this provider in the 95th percentile of 684 foot and ankle surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 55 | $709 |
| Ondansetron OdtOndansetron | 47 | $377 |
| Tramadol Hcl | 58 | $244 |
| Cephalexin | 43 | $163 |
| Meloxicam | 62 | $144 |
| Methylprednisolone | 19 | $64 |
Paid to pharmacies, not to this prescriber.
Other foot and ankle surgery in Pearland
- William McGarveyKaty$3.5M
- Eugene CurryDallas$3.1M
- Graham HamiltonEdinburg$2.1M
- Mark DaltonAustin$1.9M
- Kevin VarnerHouston$1.1M
- Paul KimDallas$928K
- Sherman NaglerHouston$602K
- John EarlyDallas$553K
- Michael DowneySouthlake$475K
- Abdul NurudeenHouston$404K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.